Form D — NBO Pharma Inc.
0002103906-26-000001 · filed Jan 22, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(c)
- Reported offering amount
- $7,640,217
- Reported amount sold
- $7,640,217
- Minimum investment
- $10,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NBO Pharma Inc.
- CIK
- 2103906
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 64 QUARRY LANE
BEDFORD, New York 10506 - Phone
- 914-645-1130
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Fredric David Price · Executive OfficerBedford, New York Find on LinkedIn ↗
-
Robert Friedman · DirectorTeaneck, New Jersey Find on LinkedIn ↗
-
Colin Foster · DirectorWoodbridge, Connecticut Find on LinkedIn ↗
-
Bard Geesaman · DirectorMarlboro, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗